SK287145B6 - Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie - Google Patents

Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie Download PDF

Info

Publication number
SK287145B6
SK287145B6 SK130-2000A SK1302000A SK287145B6 SK 287145 B6 SK287145 B6 SK 287145B6 SK 1302000 A SK1302000 A SK 1302000A SK 287145 B6 SK287145 B6 SK 287145B6
Authority
SK
Slovakia
Prior art keywords
thiazepine
ethyl
hydroxyethoxy
dibenzo
piperazinyl
Prior art date
Application number
SK130-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK1302000A3 (en
Inventor
Evan William Snape
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of SK1302000A3 publication Critical patent/SK1302000A3/sk
Publication of SK287145B6 publication Critical patent/SK287145B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
  • Liquid Crystal Substances (AREA)
SK130-2000A 1997-08-01 1998-07-28 Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie SK287145B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (en) 1997-08-01 1998-07-28 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number Publication Date
SK1302000A3 SK1302000A3 (en) 2000-06-12
SK287145B6 true SK287145B6 (sk) 2010-01-07

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
SK130-2000A SK287145B6 (sk) 1997-08-01 1998-07-28 Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie

Country Status (32)

Country Link
US (2) US6372734B1 (xx)
EP (2) EP1589008B1 (xx)
JP (2) JP2001512109A (xx)
KR (1) KR20010022241A (xx)
CN (1) CN1125058C (xx)
AT (2) ATE496037T1 (xx)
AU (1) AU739255B2 (xx)
BG (1) BG64796B1 (xx)
BR (1) BR9811061A (xx)
CA (1) CA2295792C (xx)
CY (2) CY2200161T2 (xx)
CZ (1) CZ299225B6 (xx)
DE (4) DE98936529T1 (xx)
EE (1) EE04550B1 (xx)
ES (2) ES2296568T3 (xx)
GB (2) GB9716161D0 (xx)
HK (2) HK1029992A1 (xx)
HU (1) HU228620B1 (xx)
ID (1) ID24219A (xx)
IL (1) IL133618A (xx)
MY (1) MY120999A (xx)
NO (1) NO20000484L (xx)
NZ (1) NZ501914A (xx)
PL (1) PL338384A1 (xx)
PT (2) PT1000043E (xx)
RU (1) RU2224754C2 (xx)
SI (2) SI1589008T1 (xx)
SK (1) SK287145B6 (xx)
TR (1) TR200000848T2 (xx)
TW (1) TW533207B (xx)
WO (1) WO1999006381A1 (xx)
ZA (1) ZA986904B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030216376A1 (en) * 2002-03-20 2003-11-20 Revital Lifshitz-Liron Crystalline forms of quetiapine hemifumarate
WO2004076431A1 (en) * 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
US7238686B2 (en) * 2003-03-03 2007-07-03 Hetero Drugs Limited Polymorphs of quetiapine fumarate
WO2004089957A1 (en) 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
US7687622B2 (en) 2005-04-14 2010-03-30 Teva Pharmaceutical Industries, Ltd Process for preparing quetiapine fumarate
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
WO2007036599A1 (en) 2005-09-30 2007-04-05 Fermion Oy New crystallization process of quetiapine hemifumarate
US8044039B2 (en) 2005-10-28 2011-10-25 Fermion Oy Quetiapine hemifumarate purification by crystallization
CN101360503A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 液体制剂
EP1951257A4 (en) * 2005-11-18 2008-11-05 Astrazeneca Ab CRYSTALLINE FORMS
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
US20090215744A1 (en) * 2005-11-18 2009-08-27 Astrazeneca Ab Solid Formulations
CN101360724A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 盐形式
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
ATE480227T1 (de) 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
WO2008121415A2 (en) * 2007-03-29 2008-10-09 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
US8101597B2 (en) * 2007-05-07 2012-01-24 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
ES2535730T3 (es) * 2007-12-05 2015-05-14 Janssen Pharmaceutica, N.V. Agonistas TRPA1 de dibenzoazepinas y dibenzooxazepinas
DK2262486T3 (da) 2008-08-01 2013-03-25 Krka Tovarna Zdravil D D Novo Mesto Quetiapin sammensætning
WO2010033270A1 (en) * 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010100623A1 (en) 2009-03-04 2010-09-10 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
WO2013024072A1 (en) 2011-08-12 2013-02-21 Qiagen Gmbh Method for isolating nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
TW533207B (en) 2003-05-21
US6372734B1 (en) 2002-04-16
AU8549898A (en) 1999-02-22
RU2224754C2 (ru) 2004-02-27
ES2296568T1 (es) 2008-05-01
EE200000062A (et) 2000-10-16
WO1999006381A1 (en) 1999-02-11
NZ501914A (en) 2001-09-28
US20020147186A1 (en) 2002-10-10
ID24219A (id) 2000-07-13
SI1000043T1 (sl) 2010-01-29
JP2009102345A (ja) 2009-05-14
PT1000043E (pt) 2009-11-30
PT1589008E (pt) 2011-03-23
CY2200161T2 (el) 2010-07-28
GB9814882D0 (en) 1998-09-09
ES2296575T3 (es) 2010-02-05
CN1125058C (zh) 2003-10-22
DE98936529T1 (de) 2008-11-20
GB9716161D0 (en) 1997-10-08
ES2296575T1 (es) 2008-05-01
NO20000484D0 (no) 2000-01-31
EP1589008B1 (en) 2011-01-19
MY120999A (en) 2005-12-30
BG64796B1 (bg) 2006-04-28
DE69841216D1 (de) 2009-11-19
KR20010022241A (ko) 2001-03-15
HK1029992A1 (en) 2001-04-20
HUP0002663A3 (en) 2001-10-29
PL338384A1 (en) 2000-10-23
AU739255B2 (en) 2001-10-04
ATE496037T1 (de) 2011-02-15
SK1302000A3 (en) 2000-06-12
CA2295792A1 (en) 1999-02-11
ATE444959T1 (de) 2009-10-15
HU228620B1 (en) 2013-04-29
TR200000848T2 (tr) 2000-08-21
BR9811061A (pt) 2000-09-19
CA2295792C (en) 2007-04-17
CZ299225B6 (cs) 2008-05-21
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
EP1000043A1 (en) 2000-05-17
BG104176A (en) 2000-08-31
SI1589008T1 (sl) 2011-04-29
ZA986904B (en) 1999-02-01
HK1081962A1 (en) 2006-05-26
DE69842104D1 (de) 2011-03-03
JP2001512109A (ja) 2001-08-21
CY2200162T2 (el) 2010-07-28
EE04550B1 (et) 2005-10-17
EP1000043B1 (en) 2009-10-07
DE05011169T1 (de) 2008-11-06
NO20000484L (no) 2000-03-16
CN1265101A (zh) 2000-08-30
HUP0002663A2 (hu) 2001-09-28
EP1589008A1 (en) 2005-10-26
ES2296568T3 (es) 2011-05-06
CZ2000341A3 (cs) 2000-05-17

Similar Documents

Publication Publication Date Title
SK287145B6 (sk) Farmaceutická kompozícia obsahujúca kryštalický 11-(4-(2-(2- hydroxyetoxy)etyl)-1-piperazinyl)dibenzo[b,f][1,4]tiazepín, spôsob čistenia tohto tiazepínu, spôsob prípravy kryštalického 11-(4-(2-(2-hydroxyetoxy)etyl)-1- piperazinyl)dibenzo[b,f][1,4]tiazepínu a jeho použitie
WO2003074525A1 (fr) Compose heterocyclique azote
JP2008509953A (ja) ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用
EA016141B1 (ru) Цинковая соль розувастатина
CZ2001775A3 (cs) Krystalické formy EtO2C-CH2-(R)Cgl-Aze-Pab-OH
AU1641592A (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
HU226410B1 (en) Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
SK2722002A3 (en) Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
CA2164296C (en) Heterocyclic chemistry
MXPA00000511A (en) A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
JPH07118262A (ja) 新規１，２−ジチオール−３−チオン誘導体
KR840001621B1 (ko) 글루코사민의 니코틴산유도체의 제조방법
RU2242472C1 (ru) Этаноляты n-(5-циклопропил-1-хинолин-5-ил-1н-пиразол-4-карбонил)гуанидина, способ их получения, фармацевтическая композиция на основе этих соединений и способ получения мезилатной соли n-(5-циклопропил-1-хинолин-5-ил-1н-пиразол-4-карбонил)гуанидина
WO1993004053A1 (en) Substituted thiazepines as central nervous system agents
WO2003042161A1 (en) Venlafaxine hydrochloride polymorphs
EP1785411A1 (en) Protriptyline hydrochloride crystalline form
IL27537A (en) Basically substituted oximes of 6,11-dihydrodibenzo-(b,e)-oxepinor-thiepin-11-ones and their production
HUT70181A (en) Novel arylpiperidine, process for producing thereof and pharmaceutical compositions comprising these compound
JPH0641461B2 (ja) ３−アミノ−２，３−ジヒドロ−１−ベンゾキセピン化合物、その製造法及び該化合物を含有する、抗抑圧作用を有する医薬調剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160728